[Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate.]
[Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate.] Arch Pediatr. 2013 Dec 2; Authors: Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC Abstract…
Suggested reading